NYSE - Delayed Quote • USD
Stryker Corporation (SYK)
At close: 4:00 PM EDT
After hours: 5:53 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 24 | 23 | 28 | 28 |
Avg. Estimate | 2.36 | 2.85 | 11.85 | 13.26 |
Low Estimate | 2.28 | 2.76 | 11.46 | 12.11 |
High Estimate | 2.48 | 2.96 | 12 | 13.66 |
Year Ago EPS | 2.14 | 2.54 | 10.6 | 11.85 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 22 | 22 | 28 | 27 |
Avg. Estimate | 5.1B | 5.4B | 22.18B | 23.87B |
Low Estimate | 5B | 5.34B | 22.01B | 23.48B |
High Estimate | 5.14B | 5.59B | 22.34B | 24.32B |
Year Ago Sales | 4.56B | 4.82B | 20.5B | 22.18B |
Sales Growth (year/est) | 11.90% | 12.00% | 8.20% | 7.60% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 2 | 2.38 | 2.43 | 3.27 |
EPS Actual | 2.14 | 2.54 | 2.46 | 3.46 |
Difference | 0.14 | 0.16 | 0.03 | 0.19 |
Surprise % | 7.00% | 6.70% | 1.20% | 5.80% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 2.36 | 2.85 | 11.85 | 13.26 |
7 Days Ago | 2.36 | 2.85 | 11.85 | 13.26 |
30 Days Ago | 2.36 | 2.85 | 11.85 | 13.25 |
60 Days Ago | 2.36 | 2.85 | 11.85 | 13.25 |
90 Days Ago | 2.5 | 2.82 | 11.56 | 12.86 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | 1 | 3 | 2 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 1 | -- | -- | 2 |
Growth Estimates
CURRENCY IN USD | SYK | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 10.30% | -- | -- | 1.50% |
Next Qtr. | 12.20% | -- | -- | 11.40% |
Current Year | 11.80% | -- | -- | 5.20% |
Next Year | 11.90% | -- | -- | 13.40% |
Next 5 Years (per annum) | 11.12% | -- | -- | 11.09% |
Past 5 Years (per annum) | 8.95% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | RBC Capital: Outperform to Outperform | 4/15/2024 |
Maintains | TD Cowen: Buy to Buy | 4/11/2024 |
Maintains | Evercore ISI Group: Outperform to Outperform | 4/4/2024 |
Maintains | Citigroup: Buy to Buy | 4/3/2024 |
Reiterates | RBC Capital: Outperform to Outperform | 2/15/2024 |
Maintains | Citigroup: Buy to Buy | 1/31/2024 |
Related Tickers
MDT Medtronic plc
80.38
-1.12%
BSX Boston Scientific Corporation
72.91
+5.68%
ZBH Zimmer Biomet Holdings, Inc.
121.17
-0.29%
EW Edwards Lifesciences Corporation
88.61
+0.98%
ABT Abbott Laboratories
106.89
-0.65%
DXCM DexCom, Inc.
137.87
+2.89%
INSP Inspire Medical Systems, Inc.
234.19
+0.11%
PODD Insulet Corporation
167.25
-0.01%
ALGN Align Technology, Inc.
313.78
+0.61%
SWAV Shockwave Medical, Inc.
328.87
+0.10%